Dr. Joel Salinas, a behavioral neurologist and associate professor at NYU Grossman School of Medicine, discusses what’s ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a ...

Dementia affects more than 6 million Americans and accounts for more than 100,000 deaths each year, with a startling NYU ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

In the U.S., key risk factors for Alzheimer's disease were tied to cognitive function as early as ages 24 to 44. (Lancet ...

A team of researchers from the Institute for Basic Science (IBS) in South Korea has made an important discovery that could ...

Tired of repeating yourself? Caregivers, stop correcting! Experts reveal a better way to connect with Alzheimer’s patients ...

The Alzheimer’s Association invites the community to register for 2025 Walks to End Alzheimer’s, taking place across the region, this fall. “Now is the moment we’ve been waiting for,” said Annemarie ...

What’s exciting is that medications that block CXCR3 are already being tested for other health problems, like arthritis. If ...

A vaccine designed to help protect you from an extremely painful viral infection has another important benefit. A new study ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...